首页> Biomedicines> TLR7 Agonist GS-9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV<sub>SF162P3</sub>-Infected Rhesus Monkeys.

TLR7 Agonist GS-9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV<sub>SF162P3</sub>-Infected Rhesus Monkeys.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhe,Cong

第一单位： MOH Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Comparative Medicine Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.;Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

作者： Zhe,Cong ^[1] ; Yuting,Sun ^[2] ; Cui,Dang ^[3] ; Chenbo,Yang ^[3] ; Jingjing,Zhang ^[3] ; Jiahan,Lu ^[3] ; Ting,Chen ^[3] ; Qiang,Wei ^[1] ; Wei,Wang ^[3] ; Jing,Xue ^[1]

作者单位： MOH Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Comparative Medicine Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.;Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. ^[1] MOH Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Comparative Medicine Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.;Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China. ^[2] MOH Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Comparative Medicine Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. ^[3]

关键词 CD8+ T cell response GS–9620 SHIVSF162P3 latency-reversing agent nicotinamide rhesus macaques

DOI 10.3390/biomedicines11061707

PMID 37371802

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicines

2023年11卷6期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Biomedicines

2023年11卷6期

检索历史清除

TLR7 Agonist GS-9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV<sub>SF162P3</sub>-Infected Rhesus Monkeys.

Biomedicines

相似文献

同项目论文

Biomedicines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

TLR7 Agonist GS-9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV<sub>SF162P3</sub>-Infected Rhesus Monkeys.

Biomedicines

相似文献

同项目论文

Biomedicines

相关期刊

检索历史清除